DarioHealth Corp.
DRIONasdaq
$6.81
↑ +0.7%Jul 17 close · end-of-day
Price
1Y↓ -52.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$44.9M
Enterprise Value
$55.8M
P/E
0.8
P/S
2.1
P/B
0.7
EV/EBITDA
—
PEG
0.0
FCF Yield
-56.7%
Dividend Yield
—
Revenue (TTM)
$21.2M
Net Income (TTM)
-$40.7M
Free Cash Flow (TTM)
-$25.4M
Gross Margin
56.5%
Operating Margin
-163.1%
Net Margin
-192.2%
ROE
-65.3%
ROIC
-37.2%
Debt / Equity
0.5
Net Cash
-$10.9M
Return 1Y
-51.3%
Company profile
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs.
- CEO
- Erez Raphael
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 200
- Headquarters
- New York
- Website
- mydario.com
Management & directors
- Franco-Yehuda ChenChief Financial Officer
- Nelson Steven CharlesPresident and CCO
- Raphael ErezChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
DRIO Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$5.6M↓ -17.3%
Diluted EPS$1.25↓ -56.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $7.6M | $20.5M | $27.7M | $20.4M | $27.0M | $22.4M |
| Gross profit | $2.5M | $4.0M | $9.7M | $6.0M | $13.3M | $12.7M |
| Operating income | -$29.9M | -$76.5M | -$56.8M | -$56.2M | -$57.7M | -$36.7M |
| Net income | -$29.4M | -$76.8M | -$62.2M | -$59.4M | -$42.7M | -$41.7M |
| Diluted EPS | $4.01 | $4.07 | $2.54 | $1.93 | $12.27 | $10.12 |
| Operating cash flow | -$17.7M | -$50.4M | -$47.8M | -$30.4M | -$38.6M | -$25.9M |
| Free cash flow | -$17.9M | -$50.7M | -$48.3M | -$31.0M | -$38.7M | -$26.1M |
| Gross margin | 33.2% | 19.3% | 34.9% | 29.4% | 49.1% | 56.6% |
| Operating margin | -394.7% | -372.9% | -205.4% | -276.1% | -213.6% | -163.9% |
| Net margin | -388.7% | -374.2% | -224.9% | -292.0% | -158.1% | -186.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3M | $7.4M | $7.6M | $6.8M | $5.4M | $5.0M | $5.2M | $5.6M |
| Gross profit | $2.8M | $3.9M | $4.2M | $3.9M | $3.0M | $3.0M | $2.8M | $3.2M |
| Operating income | -$16.2M | -$12.0M | -$11.7M | -$9.4M | -$9.2M | -$9.5M | -$8.6M | -$7.3M |
| Net income | -$13.6M | -$12.3M | -$9.6M | -$9.2M | -$13.0M | -$10.5M | -$9.0M | -$8.2M |
| Diluted EPS | $0.08 | $4.91 | $7.08 | $2.87 | $0.18 | $2.96 | $4.11 | $1.25 |
| Operating cash flow | -$11.4M | -$7.4M | -$6.7M | -$6.7M | -$6.0M | -$7.3M | -$5.9M | -$6.0M |
| Free cash flow | -$11.4M | -$7.4M | -$6.8M | -$6.7M | -$6.1M | -$7.4M | -$5.9M | -$6.1M |
| Gross margin | 44.1% | 52.2% | 55.3% | 57.5% | 55.2% | 60.2% | 53.6% | 57.3% |
| Operating margin | -258.8% | -162.1% | -153.4% | -139.4% | -171.4% | -189.4% | -163.7% | -130.9% |
| Net margin | -217.6% | -166.1% | -126.7% | -136.7% | -241.9% | -209.0% | -172.6% | -147.7% |
Company news
Jul 2, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2025-09-11 | Nelson Steven Charles· President and CCO | Award | 30,000 | $0.00 | $0.00 | filing |
| 2025-09-11 | STERN ADAM K | Award | 20,000 | $0.00 | $0.00 | filing |
| 2025-09-11 | Leisure Lawrence B. | Award | 20,000 | $0.00 | $0.00 | filing |
| 2025-09-11 | Shaked Yoav | Award | 20,000 | $0.00 | $0.00 | filing |
| 2025-09-11 | Raphael Erez· Chief Executive Officer | Award | 60,000 | $0.00 | $0.00 | filing |
| 2025-09-11 | Franco-Yehuda Chen· Chief Financial Officer | Award | 5,000 | $0.00 | $0.00 | filing |
| 2025-09-11 | MCGRATH DENNIS M | Award | 20,000 | $0.00 | $0.00 | filing |
| 2025-09-11 | Karah Hila | Award | 20,000 | $0.00 | $0.00 | filing |
| 2025-09-11 | Matheis Dennis | Award | 20,000 | $0.00 | $0.00 | filing |
| 2025-08-27 | Nelson Steven Charles· President and CCO | Buy | 40,000 | $0.53 | $21,200.00 | filing |
Latest 10 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.